Memorial Sloan Kettering Cancer Center
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Phase 2
Completed
- Conditions
- Extragonadal Germ Cell TumorKidney CancerOvarian CancerRetinoblastomaBrain and Central Nervous System TumorsChildhood Germ Cell TumorLiver CancerNeuroblastomaSarcoma
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-11-25
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 22
- Registration Number
- NCT00024258
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States